Impaired protection against Mycobacterium bovis bacillus Calmette-Guerin infection in IL-15-deficient mice

被引:30
|
作者
Saito, K
Yajima, T
Kumabe, S
Doi, T
Yamada, H
Sad, S
Shen, H
Yoshikai, Y [1 ]
机构
[1] Kyushu Univ, Div Host Def, Med Inst Bioregulat, Fukuoka 8128582, Japan
[2] Natl Res Council Canada, Cellular Immunol Lab, Inst Biol Sci, Ottawa, ON, Canada
[3] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 04期
关键词
D O I
10.4049/jimmunol.176.4.2496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the potential role of endogenous IL-15 in mycobacterial infection, we examined protective immunity in IL-15-deficient (IL-15(-/-)) mice after infection with Mycobacterium bovis bacillus Calmette-Guerin (BCG) or recombinant OVA-expressing BCG (rBCG-OVA). IL-15(-/-) mice exhibited an impaired protection in the lung on day 120 after BCG infection as assessed by bacterial growth. CD4(+) Th1 response capable of producing IFN-gamma was normally detected in spleen and lung of IL-15(-/-) mice on day 120 after infection. Although Ag-specific CD8 responses capable of producing IFN-gamma and exhibiting cytotoxic activity were detected in the lung on day 21 after infection with rBCG-OVA, the responses were severely impaired on days 70 and 120 in IL-15(-/-) mice. The degree of proliferation of Ag-specific CD8(+) T cells in IL-15(-/-) mice was similar to that in wild-type mice during the course of infection with rBCG-OVA, whereas sensitivity to apoptosis of Ag-specific CD8(+) T cells significantly increased in IL-15(-/-) mice. These results suggest that IL-15 plays an important role in the development of long-lasting protective immunity to BCG infection via sustaining CD8 responses in the lung.
引用
收藏
页码:2496 / 2504
页数:9
相关论文
共 50 条
  • [1] Mycobacterium bovis-Bacillus Calmette-Guerin and asthma
    SHEN Huahao ZHANG Gensheng and WANG Pingli Department of Respiratory Medicine Second Hospital of Zhejiang University Medical College Hangzhou China Shen HH Zhang GS and Wang PL
    ChineseMedicalJournal, 2005, (11) : 942 - 947
  • [2] Mycobacterium bovis-Bacillus Calmette-Guerin and asthma
    Shen, HH
    Zhang, GS
    Wang, PL
    CHINESE MEDICAL JOURNAL, 2005, 118 (11) : 942 - 947
  • [3] Mycobacterium bovis-Bacillus Calmette-Guerin and asthma
    SHEN Hua-hao
    中华医学杂志(英文版), 2005, (11) : 942 - 947
  • [4] Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses
    Umemura, M
    Nishimura, H
    Hirose, K
    Matsuguchi, T
    Yoshikai, Y
    JOURNAL OF IMMUNOLOGY, 2001, 167 (02): : 946 - 956
  • [5] Membrane subproteomic analysis of Mycobacterium bovis bacillus Calmette-Guerin
    Zheng, Jianhua
    Wei, Candong
    Leng, Wenchuan
    Dong, Jie
    Li, Rui
    Li, Weijun
    Wang, Jin
    Zhang, Zongde
    Jin, Qi
    PROTEOMICS, 2007, 7 (21) : 3919 - 3931
  • [6] Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases
    Barlan, I
    Bahceciler, NN
    Akdis, M
    Akdis, CA
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2006, 26 (02) : 365 - +
  • [7] Killed but Metabolically Active Mycobacterium bovis bacillus Calmette-Guerin Retains the Antitumor Ability of Live bacillus Calmette-Guerin
    Secanella-Fandos, Silvia
    Noguera-Ortega, Estela
    Olivares, Francesc
    Luquin, Marina
    Julian, Esther
    JOURNAL OF UROLOGY, 2014, 191 (05): : 1422 - 1428
  • [9] Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guerin
    Hamerman, JA
    Aderem, A
    JOURNAL OF IMMUNOLOGY, 2001, 167 (04): : 2227 - 2233
  • [10] Disseminated infection due to Mycobacterium bovis after intravesical instillation of bacillus Calmette-Guerin
    Santos Seoane, Sagrario Maria
    Diaz Fernandez, Vanesa
    Rivas Carmenado, Maria Eugenia
    Fernandez Pantiga, Aida
    MEDICINA CLINICA, 2018, 150 (07): : 289 - 289